- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.04. | Movano Health's Proprietary Cuffless Blood Pressure Device Once Again Achieves Accuracy Commensurate with the FDA's Requirements | 79 | PR Newswire | Leveraging the Company's System-on-a-Chip (SoC), the clinical study results are another significant step forward in commercializing a cuffless, radio frequency (RF)-enabled blood pressure... ► Artikel lesen | |
| 09.04. | Movano Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 04.02. | Movano Health kicks off cuffless blood pressure device study | 2 | MassDevice | ||
| 02.01. | Movano Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| MOVANO Aktie jetzt für 0€ handeln | |||||
| 02.01. | Movano Health expands board with healthcare investment expert | 2 | Investing.com | ||
| 02.01. | Movano Health erweitert Vorstand um Experten für Gesundheitsinvestitionen | 2 | Investing.com Deutsch | ||
| 02.12.24 | FDA clears Movano smart ring's pulse oximetry feature | 1 | MassDevice | ||
| 02.12.24 | Movano Health Receives FDA Clearance for EvieMED Ring | 162 | PR Newswire | Company's first 510(k) clearance unlocks a TAM of $40 billion in healthcare B2B opportunities PLEASANTON, Calif., Dec. 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer... ► Artikel lesen | |
| 14.11.24 | Movano Health Reports Q3 2024 Financial Results and Provides Business Update | 125 | PR Newswire | Highlights successful Evie Ring back-in-stock execution
Updates status of EvieMED 510(k) application review
Focuses on launch of EvieMED and securing B2B opportunities... ► Artikel lesen | |
| 07.11.24 | Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device | 130 | PR Newswire | New hardware boasts significant improvements to reduce noise and generate higher fidelity signals
PLEASANTON, Calif., Nov. 7, 2024 /PRNewswire/ -- Movano Health... ► Artikel lesen | |
| 04.11.24 | Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split | 148 | PR Newswire | Company Continues to Work with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders
PLEASANTON, Calif., Nov. 4, 2024... ► Artikel lesen | |
| 04.11.24 | Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED | 133 | PR Newswire | Company remains optimistic on the potential for this pioneering healthcare solution
PLEASANTON, Calif., Nov. 4, 2024 /PRNewswire/ -- Movano Health (NASDAQ: MOVE)... ► Artikel lesen | |
| 31.10.24 | Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split | 114 | PR Newswire | Company Communicating with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders
PLEASANTON, Calif., Oct. 31, 2024 /PRNewswire/... ► Artikel lesen | |
| 25.10.24 | Movano Health Announces Reverse Stock Split | 187 | PR Newswire | Shares Expected to Begin Trading on Split-Adjusted Basis on October 29, 2024
PLEASANTON, Calif., Oct. 25, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE)... ► Artikel lesen | |
| 24.10.24 | Movano Health Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase | 111 | PR Newswire | A successful response to requests for additional information would bring the Company one step closer to introducing this pioneering healthcare product to the market
PLEASANTON, Calif., Oct. 24,... ► Artikel lesen | |
| 10.10.24 | Movano Health Provides Update on FDA Review of EvieMED Ring | 158 | PR Newswire | The Company continues to work closely with the FDA to bring this pioneering healthcare product to market
PLEASANTON, Calif., Oct. 10, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced... ► Artikel lesen | |
| 14.08.24 | Movano Health Reports Q2 2024 Financial Results and Provides Business Update | 232 | PR Newswire | Prepares for September 17, 2024, Evie Ring back in stock dateAnnounces brand partnership with digital creator Heidi D'AmelioFocuses on launch of EvieMED and securing B2B opportunitiesConference Call... ► Artikel lesen | |
| 05.08.24 | Movano Health Provides Progress Update on EvieMED Regulatory Filing | 136 | PR Newswire | Company continues to work with FDA to bring this pioneering healthcare product to market
PLEASANTON, Calif., Aug. 5, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) plans to meet with the FDA... ► Artikel lesen | |
| 10.06.24 | MIT Selects Movano Health for Groundbreaking Study on Long COVID and Chronic Lyme Disease | 224 | PR Newswire | Pioneering partnership advances innovative health monitoring, setting the stage for future enterprise opportunities.
PLEASANTON, Calif., June 10, 2024 /PRNewswire/ -- In a strategic move that... ► Artikel lesen | |
| 15.05.24 | Movano Health Reports Q1 2024 Financial Results and Provides Business Update | 196 | PR Newswire | Submits exemplary Sp02 clinical trial results as part of FDA 510(k) clearance processPlans launch of Evie Med and focuses on B2B opportunitiesPlans arterial blood pressure study for JuneConference... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 224,50 | -18,60 % | UnitedHealth Group-Aktie leicht im Minus (338,6583 €) | Im US-amerikanischen Wertpapierhandel liegt die Aktie der UnitedHealth Group gegenwärtig im Minus. Die Aktie notiert derzeit bei 381,59 US-Dollar. Die UnitedHealth Group-Aktie verzeichnet aktuell ein... ► Artikel lesen | |
| FRESENIUS | 42,450 | +1,63 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 48,600 | +0,93 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 60 auf 56 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Richard Felton passte... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 50,56 | +1,12 % | Fresenius Medical Care: Analysten pessimistisch - Die Kasse klingelt! | ||
| HIMS & HERS HEALTH | 49,010 | -10,50 % | Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month | ||
| THERMO FISHER | 355,50 | -2,19 % | Cybin taps Thermo Fisher for potential commercial manufacturing of CYB003 | ||
| GERRESHEIMER | 61,60 | -0,48 % | EQS-News: Gerresheimer AG: Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab | EQS-News: Gerresheimer AG
/ Schlagwort(e): Sonstiges/Nachhaltigkeit
Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab
12.05.2025... ► Artikel lesen | |
| NUTEX HEALTH | 170,54 | +7,52 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
| ECKERT & ZIEGLER | 62,15 | -0,48 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler startet mit Ergebniswachstum in Q1 2025 und bestätigt Jahresprognose | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Quartalsergebnis
Eckert & Ziegler startet mit Ergebniswachstum in Q1 2025 und bestätigt Jahresprognose
13.05.2025 / 07:45... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 61,40 | -0,81 % | Ihre wichtigsten Termine: Alle Blicke auf: Boeing, Bayer, Carl Zeiss Meditec, Rheinmetall, Sixt & Jenoptik | © Foto: Bayer AGGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 07:00 Uhr, Deutschland:... ► Artikel lesen | |
| KINDLY MD | 11,740 | +54,07 % | David Bailey and Bitcoin-Native Holding Company Nakamoto Announce Merger with KindlyMD to Establish Bitcoin Treasury | Raises $510 Million PIPE and $200 Million in Convertible Notes Marking Largest Capital Raise to Launch a Bitcoin Treasury and the Largest PIPE for Any Public Crypto-Related Transaction
David Bailey... ► Artikel lesen | |
| DRAEGERWERK | 61,30 | +1,32 % | EQS-News: Drägerwerk AG & Co. KGaA: Hauptversammlung von Dräger beschließt Dividendenerhöhung - Aufnahme der Vorzugsaktien in den TecDAX | EQS-News: Drägerwerk AG & Co. KGaA
/ Schlagwort(e): Hauptversammlung/Dividende
Drägerwerk AG & Co. KGaA: Hauptversammlung von Dräger beschließt Dividendenerhöhung - Aufnahme der... ► Artikel lesen | |
| GENEDX | 59,50 | -0,02 % | GeneDx Holdings stock trades higher as upgraded at Jefferies | ||
| INTUITIVE SURGICAL | 496,95 | -1,92 % | Intuitive Surgical Promotes President Dave Rosa As CEO | SUNNYVALE (dpa-AFX) - Intuitive Surgical, Inc. (ISRG), a biotechnology company, on Thursday announced the promotion of President Dave Rosa as Chief Executive Officer, effective from July 1.... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 54,05 | -1,28 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |
Das Unternehmen MOVANO INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,020 (-1,87 %) liegt der Kurs bei 1,050 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MOVANO INC finden Sie auf Wallstreet Online.